Technical420 Site Search

 Cannabis stocks continue to rally and with the presidential election right around the corner, we do not expect this trend to end anytime soon.That being said, we do not recommend diving head first into the industry as the market is nothing like it was in early 2014 when you could…

GW Pharmaceuticals (GWPH) shares jumped more than 20% after it reported that it was working with Morgan Stanley after other drug makers approached it to express interest in an acquisition, according to people familiar with the matter.GW is one of the leaders in the cannabis industry. The British biopharmaceutical company…

The Canadian medical cannabis industry continues to be a bright spot in the cannabis sector as its constituents are led by management teams that continue to execute on business initiatives and create value for shareholders.One the biggest developments in 2015 was the victory by Justin Trudeau and the Liberal Party…

The cannabis sector continues to be one of the most attractive places to invest as the market continues to be negatively impacted by global growth concerns, increasing interest rates, and terror inspired attacks.Today, Goldman Sachs (GS), one of the largest banks in the world, downgraded its outlook on global equities…

In a letter to senators, the Drug Enforcement Administration said that they plan to decide whether marijuana should be reclassified under federal law in the first half of 2016.The letter was sent in response to a letter from Democratic Senator Elizabeth Warren (Massachusetts) and sever other Democratic Senators in 2015.…

The termination of the $160 billion merger between Pfizer Inc. (PFE) and Allergan Plc (AGN) has been confirmed.The driving factor behind this decision stems from the rules issued by the United States Treasury Department which are focused on making tax inversion deals less profitable.Moving Addresses, Not AssetsPresident Obama said the…

Earlier this month, GW Pharmaceuticals (GWPH) reported positive results from the first Phase 3 Clinical study for its Epidiolex product and this has served as a catalyst for several publicly traded cannabis companies.This rally can be described as nothing short of a volatile explosion upward as some of the stocks…

One of the sectors that have been hit the hardest during the last three months is the biotech sector and many investors are wondering if it is time to buy. Although recent weakness has made many biotech investments look attractive, we remain on the sidelines with many blue chip investments…

Since, growing hemp has been illegal for almost a full century, researchers have been unable to learn all of the benefits associated with it. In 1916, Jason Merrill and Lyster Dewey, the chief scientists at the United States Department of Agriculture created paper made from the inner portion of the…

The United States cannabis industry has been one of the hottest places to invest over the last year; Canada, however, has not been too far behind. One the most important developments during 2014 was the implementation of the new federal medical marijuana program in Canada, Marihuana for Medical Purposes Regulations…